213 related articles for article (PubMed ID: 16697054)
1. Emerging cancer therapeutic opportunities target DNA-repair systems.
Ding J; Miao ZH; Meng LH; Geng MY
Trends Pharmacol Sci; 2006 Jun; 27(6):338-44. PubMed ID: 16697054
[TBL] [Abstract][Full Text] [Related]
2. DNA repair inhibition and cancer therapy.
Martin NM
J Photochem Photobiol B; 2001 Oct; 63(1-3):162-70. PubMed ID: 11684463
[TBL] [Abstract][Full Text] [Related]
3. DNA repair inhibition: a selective tumour targeting strategy.
Madhusudan S; Hickson ID
Trends Mol Med; 2005 Nov; 11(11):503-11. PubMed ID: 16214418
[TBL] [Abstract][Full Text] [Related]
4. Targeting the DNA damage response in oncology: past, present and future perspectives.
Basu B; Yap TA; Molife LR; de Bono JS
Curr Opin Oncol; 2012 May; 24(3):316-24. PubMed ID: 22476188
[TBL] [Abstract][Full Text] [Related]
5. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
[TBL] [Abstract][Full Text] [Related]
6. Cadmium-induced adaptive response in cells of Chinese hamster ovary cell lines with varying DNA repair capacity.
Pan Y; Yuan D; Zhang J; Xu P; Chen H; Shao C
Radiat Res; 2009 Apr; 171(4):446-53. PubMed ID: 19397445
[TBL] [Abstract][Full Text] [Related]
7. O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance.
Gerson SL; Willson JK
Hematol Oncol Clin North Am; 1995 Apr; 9(2):431-50. PubMed ID: 7642472
[TBL] [Abstract][Full Text] [Related]
8. Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells.
Pan J; She M; Xu ZX; Sun L; Yeung SC
Cancer Res; 2005 May; 65(9):3671-81. PubMed ID: 15867362
[TBL] [Abstract][Full Text] [Related]
9. Exploiting synthetic lethal interactions for targeted cancer therapy.
Reinhardt HC; Jiang H; Hemann MT; Yaffe MB
Cell Cycle; 2009 Oct; 8(19):3112-9. PubMed ID: 19755856
[TBL] [Abstract][Full Text] [Related]
10. New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response.
Luo Y; Leverson JD
Expert Rev Anticancer Ther; 2005 Apr; 5(2):333-42. PubMed ID: 15877529
[TBL] [Abstract][Full Text] [Related]
11. Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family.
Finlay MR; Griffin RJ
Bioorg Med Chem Lett; 2012 Sep; 22(17):5352-9. PubMed ID: 22835870
[TBL] [Abstract][Full Text] [Related]
12. ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage.
Bensimon A; Schmidt A; Ziv Y; Elkon R; Wang SY; Chen DJ; Aebersold R; Shiloh Y
Sci Signal; 2010 Dec; 3(151):rs3. PubMed ID: 21139141
[TBL] [Abstract][Full Text] [Related]
13. PARP inhibitors for cancer therapy.
Curtin NJ
Expert Rev Mol Med; 2005 Mar; 7(4):1-20. PubMed ID: 15836799
[TBL] [Abstract][Full Text] [Related]
14. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
Veuger SJ; Durkacz BW
DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer.
Madhusudan S; Middleton MR
Cancer Treat Rev; 2005 Dec; 31(8):603-17. PubMed ID: 16298073
[TBL] [Abstract][Full Text] [Related]
16. Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner.
Tamakawa RA; Fleisig HB; Wong JM
Cancer Res; 2010 Nov; 70(21):8684-94. PubMed ID: 20837664
[TBL] [Abstract][Full Text] [Related]
17. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
Moumen A; Masterson P; O'Connor MJ; Jackson SP
Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
Bryant HE; Helleday T
Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
[TBL] [Abstract][Full Text] [Related]
19. ATM: HIV-1's Achilles heel?
Daniel R; Pomerantz RJ
Nat Cell Biol; 2005 May; 7(5):452-3. PubMed ID: 15867928
[No Abstract] [Full Text] [Related]
20. O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
Spiro TP; Gerson SL; Liu L; Majka S; Haaga J; Hoppel CL; Ingalls ST; Pluda JM; Willson JK
Cancer Res; 1999 May; 59(10):2402-10. PubMed ID: 10344750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
